Arbutus Biopharma Corp (NASDAQ:ABUS)

3.00
Delayed Data
As of 4:00pm ET
 -0.03 / -0.99%
Today’s Change
0.82
Today|||52-Week Range
4.75
+7.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues24.9M1.5M10.7M5.9M
 
 
 
 
 
Depreciation And Amortization589.0K1.1M2.0M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses61.2M68.7M78.8M74.0M
 
 
 
 
 
Research And Development47.3M55.3M62.7M58.0M
 
 
 
 
 
Total Operating Expenses61.8M69.8M80.8M76.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-37.0M-68.3M-70.1M-70.2M
 
 
 
 
 
Extraordinary Credit3.3M530.0K0.0032.2M
 
 
 
 
Extraordinary Charge-66.1M-424.9M-42.2M-19.6M
 
 
 
 
 
Pre-Tax Equity Earnings0.000.000.00-5.6M
 
 
Interest Expense On Debt0.00--261.0K226.0K
 
 
 
Other Expenses21.8M2.1M2.3M-1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-77.3M-489.2M-108.7M-61.4M
 
 
 
 
 
Income Taxes-16.2M-105.0M-24.3M-4.3M
 
 
 
 
 
Preferred Dividend0.000.00-911.0K-10.1M
 
 
 
Net Income-61.1M-384.2M-84.4M-57.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.5M53.1M54.7M55.3M
 
 
 
 
 
Shares To Calculate EPS Diluted45.5M53.1M54.7M55.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.34-$7.24-$1.56-$1.21
 
 
 
 
 
EPS Diluted-$1.34-$7.24-$1.56-$1.21